Objectives: Rectal application of steroids and 5-aminosalicylic acid (5-ASA) is associated with few side effects and has a high therapeutic efficacy in left-sided colitis.
UC patients suffer a type of distal UC, 6 ,7 a topical therapy should be applied due to the higher success rates and fewer side effects compared with oral therapy. Rectal application of steroids and 5-ASA is associated with fewer side effects and has a higher therapeutic efficacy in left-sided colitis, which was underused. 3, 8 On one hand, some results have proved that rectal 5-ASA is superior to rectal corticosteroids in the management of distal UC. 9, 10 On the other hand, however, other studies demonstrated a similar efficacy of both treatments. [11] [12] [13] [14] [15] [16] Although it is clearly stated that rectal 5-ASA is superior to steroid in recent European Crohn´s and Colitis Organisation (ECCO) guideline, 17, 18 the steroids used are beclomethasone dipropionate (BDP) or budesonide 15, [19] [20] [21] [22] [23] [24] [25] [26] [27] in their study, which is not available in China.
In addition, researchers also investigated whether rectal combination application of steroids and 5-ASA was superior to one single alone. Intriguingly, the results are controversial. 19, 28 Considering combination application of steroids and 5-ASA is widely used by Chinese doctors, we are interested in studying the effect of hydrocortisone/dexamethasone enema treatment with or without 5-ASA.
Therefore, a questionnaire survey was carried out in 72 gastrointestinal (GI) centres to investigate the preference of choice for the treatment of distal UC in Chinese doctors. Then, a retrospective study was carried out in four IBD centres to evaluate the efficacy of hydrocortisone/dexamethasone with or without 5-ASA enema in patients with distal active UC. Finally, Dextran sodium sulphate (DSS)-induced colitis model in mice was used to prove the effect. In this study, we try to find which is the best enema through clinical and experimental research, then it might provide a decisive evidence for Chinese doctors for their treatment of distal active UC.
F I G U R E 1
The professional title composition of doctors involving the questionnaire and treatment choices for distal active ulcerative colitis. A, A total of 286 doctors with different professional title were enrolled in the survey, and the composition was shown in the pie chart with different colour. B, In the survey, doctors chose different therapeutic schedule including oral 5-ASA only, intravenous or oral steroids, oral 5-ASA with topical 5-ASA, oral 5-ASA with topical steroids and oral 5-ASA with topical steroids and 5-ASA to treat leftsided colitis patients. The corresponding number and proportion chosen by doctors were shown in the pie chart with different colour 2 | MATERIAL S AND ME THODS
| Questionnaire survey
Questionnaire survey was carried out in 72 GI centres and 286 doctors with their informed consent. A self-administered and structured questionnaire, as described in Table S1 , was used to collect data.
| Clinical observation parameters
Mayo score, as described in Table S2 , also known as the Mayo Clinic
Score and the Disease Activity Index, was used to evaluate the effect on intra-group (before vs after) and inter-group (5-ASA enemas vs hydrocortisone/dexamethasone enemas vs combination enemas).
29
The laboratory parameters including RBC, WBC, PLT, Hb, CRP and erythrocyte sedimentation rate (ESR) were collected and analyzed before and after treatment. Annotation: The data were presented as mean ± SD. 
| Animal model

| Pathological analysis
Histological assessments of colitis and severity scores were made in a double-blinded manner after H&E staining as described in Table   S3 . 30 
| Other methods
For other Section 2, please see Supporting Information.
| Statistical analysis
The results were analyzed with different statistical methods, and P value <0.05 was considered statistically significant. A majority of our data was described with the mean and standard deviation and those data were dealt with Student's t test between any two groups. As for comparison of rate, we employed chi-square test to evaluate differences between two groups. We consulted professional teachers of statistics about the choice of specific statistical methods.
| RE SULTS
| General information of questionnaire survey
Of 286 *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001 more than five patients monthly with UC, 17.83% (51/286) treated 3-5 patients, 58.04% (166/286) treated 1-2 patients and 15.73%
(45/286) had no chance to treat patients.
| Treatment choices for distal active UC
According to the extent and severity of UC patients, doctors will choose different therapeutic schedules. Sometimes, the willingness of doctors and the tolerance and compliance of patients are responsible for the therapeutic choice. In our survey, we mainly paid attention to the choice of doctors when they treated left-sided colitis patients. As shown in Figure 1B , oral 5-ASA only was chosen by 15.38% (44/286) doctors, intravenous or oral steroids by 2.45% 
| General information of patients
General information of UC patients was summarized in Table 1 . One hundred and one patients (34 for 5-ASA, 38 for hydrocortisone/dexamethasone and 29 for hydrocortisone/dexamethasone with 5-ASA enema treatment) were selected and analyzed. Baseline demographics including case number, sex, age and duration time were found to have no significant differences among three groups. But, the severity of the disease was different between groups. The group of 5-ASA enema and hydrocortisone/dexamethasone enema had more mild to moderate patients and their combination enema group had more moderate and severe patients (Table 1) . Limited by the number of the cases, no significant difference was observed.
| The efficiency of 5-ASA or hydrocortisone/ dexamethasone or their combination enema treatment in patients with distal active UC
In order to evaluate the efficiency of 5-ASA or hydrocortisone/ dexamethasone or their combination in patients with distal active UC, Mayo score was employed and detailed results were presented in Table 2 . Compared with before treatment, the Mayo score after treatment was found to be reduced significantly in each group (P < 0.001) ( Table 2) . Clinical remission [31] [32] [33] (Mayo Clinic score ≤ 2, with no subscore > 1) occurred in 41.18% Figure 2C) . Moreover, the efficiency of different groups after treatment was analyzed and compared. After the treatment, the 5-ASA enema group and combination enema group were superior to hydrocortisone/dexamethasone enema group ( Figure 2D ; P < 0.001). Finally, we analyzed and compared clinical remission and clinical response according to the severity of disease and the results are showed in Table S5 and Figure S2 .
| Laboratory characteristics for UC patients
In addition, the laboratory indexes including red blood cell (RBC), white blood cell (WBC), platelet (PLT), haemoglobin (Hb), C-reactive protein (CRP) and ESR were also collected and analyzed before and after treatment. After treatment, CRP and ESR were observed to be markedly improved in 5-ASA enema group and combination enema group (P < 0.05), but not in hydrocortisone/dexamethasone enema group (P > 0.05). No differences in RBC, WBC, PLT and Hb were found to be altered before and after the enema treatment in each group (Table 3 ).
| The efficiency of 5-ASA or hydrocortisone/ dexamethasone or their combination enema treatment in DSS-induced colitis in mice
Seventy-one C57BL/6 mice (female) were enrolled in the experiment. About 66 mice completed the experiment and five mice died during the study, including one mouse in DSS group II, two mice in group III and two mice in group IV. The body weight recovered in each group after the enema treatment. It was more obvious in 5-ASA enema group and combination enema group compared with hydrocortisone/dexamethasone enema group. However, no statistical differences were found between 5-ASA enema group and combination enema group ( Figure 3A,B) . Similar to the changes of body weight, the shorten length of colon improved most significantly in 5-ASA enema group compared with hydrocortisone/dexamethasone enema group or combination enema group ( Figure 3C,D) , while there were no significant differences in blood stool and stool consistency among three enema groups (see Figure S1 ).
In agreement, pathological analysis showed that the therapeutic effect of 5-ASA enema group that had no statistical differences compared with combination enema group, was superior to the hydrocortisone group based on haematoxylin (H&E) staining ( Figure 3E ) and the pathological assessment of colitis severity scores (Table 4 and Figure 3F ), though each enema group had significant improvement after treatment.
| Cytokines and signalling pathways-related molecules measurement
It is well documented that cytokines secretion and persistent activa- Annotation: Total scores were the sum of score of the four parameters, and the data were presented as mean ± SD. The significance of Bold values is shown in the ( Figure 3F ).
TA B L E 4 The pathological assessment of colitis severity scores
F I G U R E 3
The treatment of 5-ASA or hydrocortisone/dexamethasone or combination enema treatment alleviated DSS-induced colitis. A-F, Acute colitis was induced with 3.5% DSS for 5 d, and then regular water for another 5 d. Drug administration via anus to the mice was implemented on the 5th to 10th day. Changes in body weight (A,B), colon shortening (C,D), mucosal histology examined by H&E staining (E, scale bar, 20 µm) and colitis severity scores (Table 4 and Figure F ) were determined in a double-blind manner. *P < 0.05, **P < 0.01,***P < 0.005 (Student's t test)
NF-κB signalling is a key process during inflammation and thus constitutes an attractive target for anti-inflammatory interventions. 35 To clarify the possible molecular mechanisms of the enema treatment, we evaluated their effects on NF-κB activation in mice with DSS-induced colitis. As shown in Figure 4F ,G, WB and IHC analysis demonstrated that the enema treatment markedly suppressed the protein expression of p-NF-κB/p65 and the 5-ASA enema group and combination enema had better effects than the hydrocortisone/ dexamethasone enema group.
| D ISCUSS I ON
As is known to all, topical 5-ASA and steroids are common therapies for UC. However, which is more effective of topical 5-ASA, steroids or their combination for the treatment of left-sided UC is still controversial. Especially, the steroids used for enema are different from those in western country. Therefore, our study aims at comparing the efficacy of 5-ASA, hydrocortisone/dexamethasone or combination enema in patients with distal active UC. The most meaningful finding of our study is that 43.01% of Chinese doctors would like to choose hydrocortisone/dexamethasone with or without 5-ASA enema for the treatment of distal UC. In addition, the results from a retrospective study and an animal experiment showed that two are no better than one-the combination enema was not superior to 5-ASA enema.
Firstly, in order to investigate the preference of GI doctors for topical treatment of distal UC, we introduced a questionnaire survey which was carried out in 72 GI centres of China. The results showed that 43.01% of the doctors would like to choose topical hydrocortisone/dexamethasone with or without 5-ASA enema. In China, some doctors think that systemic steroids are mainly used for implosive therapy for severe UC and the efficacy is superior to 5-ASA, so they take it for granted that steroid enema is better than 5-ASA enema, although it is clearly stated that topical 5-ASA is more effective than topical steroids in recent ECCO guideline. ICAM-1 are downstream effectors of NF-κB activation. 36 To further
The treatment of 5-ASA or hydrocortisone/dexamethasone or their combination enema decreased COX-2, IL-1β, IL-6, TNFand ICAM-1 expression through NF-κB signalling pathway. A-E, mRNA expression of cytokines and signalling pathway-related molecule were examined by qRT-PCR, including COX-2 (A), IL-1β (B), IL-6 (C), TNF-(D) and ICAM-1 (E). F, Protein expression of cytokines and signal pathway-related molecule were examined by Western blotting. β-actin served as a loading control. G, Representative IHC-stained sections of COX-2, TNF-, IL-1β, IL-6 and p-NF-κB/p65. Scale bars, 20 µm. *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001 (Student's t test).
explore the potential mechanism by which the drugs played a role, inflammation and signalling pathways-related molecules mentioned above were measured. With DSS exposure, inflammation occurred, the expression of related molecules including COX-2, TNF-, IL-1β, IL-6 and ICAM-1 increased and NF-κB signalling pathway was activated. After enema treatment, the inflammation-related molecules decreased to varying degrees compared with PBS enema group and the reduction was worst in hydrocortisone/dexamethasone enema group. As we know, one of the most crucial pharmacological actions of steroids for UC therapy is its powerful anti-inflammatory effect.
In the present study, unlike systematical application, topical steroid treatment may seriously influence its anti-inflammatory effect and to some extent, locally limited drug concentration may be another reason, which is responsible for the worst efficacy of hydrocortisone/dexamethasone enema.
One of the strengths about our study is that it is the first evidence of treatment choice in Chinese doctors for the distal UC through a questionnaire survey in 72 GI centres and 286 doctors.
Moreover, a retrospective study carried out in four major IBD centres with an animal experiment was used to compare the effect among 5-ASA enema, hydrocortisone/dexamethasone enema and combination enema.
There are several limitations to this study. First, the question- Second, a retrospective study was carried out instead of a prospective, controlled, randomized, double-blind study. To some certain extent, it had a few disadvantages, such as relative poor representativeness, incomplete information, lost follow-up and so on. Nevertheless, a randomized controlled trial (RCT) had already registered by these IBD centres (NCT03110198) to make up for the shortcomings. Third, unlike BDP and budesonide, which are characterized with high first-pass hepatic metabolism, hydrocortisone/ dexamethasone might be metabolized in liver. The plasma concentration or the side effects were not investigated in this study. Even though, the practical use of different steroids in China might just reflect the value and significance of our study. Finally, the aim of our study was to investigate the therapeutic effects of hydrocortisone/ dexamethasone and its combination with 5-ASA to treat left-sided UC, therefore, the side effects of hydrocortisone/dexamethasone are not be paid much more attention. and National Science-technology Support Plan [2015BAI13B07] .
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